1 SUMMARY Histone methyltransferases comprise a major class of epigenetic enzymes that are emerging as important regulators of Th cell biology. Here, Scheer et al. report that DOT1L is a key regulator of the Th cell lineage and integrity, thereby affecting Th cell-dependent responses at mucosal sites. ABSTRACT CD4 + T helper (Th) cell differentiation is controlled by lineage-specific expression of transcription factors and effector proteins, as well as silencing of lineage-promiscuous genes. Lysine methyltransferases (KMTs) comprise a major class of epigenetic enzymes that are emerging as important regulators of Th cell biology. Here, we show that the KMT DOT1L regulates Th cell function and lineage integrity. DOT1L-dependent dimethylation of lysine 79 of histone H3 (H3K79me2) is associated with lineage-specific gene expression. However, DOT1L-deficient Th cells overproduce IFN-γ under lineage-specific and lineage-promiscuous conditions. Consistent with the increased IFN-γ response, mice with a T cell-specific deletion of DOT1L are susceptible to infection with the helminth parasite Trichuris muris and resistant to the development of allergic lung inflammation. These results identify a central role for DOT1L in Th cell lineage commitment and stability, and suggest that inhibition of DOT1L may provide a novel therapeutic strategy to limit type 2 immune responses.
INTRODUCTION
Upon encounter of foreign antigens in the periphery, CD4 + T helper (Th) cells can differentiate into several distinct cell lineages that have distinct physiological properties and functions. For example, Th1 cells are induced following viral or intracellular bacterial infection, produce the cytokine interferon-γ (IFN-γ) and activate macrophages to kill infectious organisms. In contrast, Th2 cells express interleukin (IL)-4, IL-5 and IL-13 following helminth infection and are required for immunity to this class of pathogens. These cells show a distinct and mutually exclusive cell fate, as the induction of the Th1 cell lineage program by the cytokine IL-12 and the transcription factor (TF) TBET leads to the production of IFN -γ, while repressing genes that characterise differentiated Th2 cells, such as IL-4 and IL-13 and the TF GATA3. Maintenance of lineage integrity is critical for optimal responses to a wide variety of pathogens.
Epigenetic modifiers, such as histone lysine methyltransferases (KMTs) have emerged as critical regulators of Th cell differentiation and function as their activity results in a defined state of chromatin, which enables the regulation of gene expression and in turn regulates cellular development and differentiation (He et al., 2013) . We and others have previously shown that inhibition of KMTs has a profound impact on Th cell differentiation, lineage stability and function. For example, EZH2-dependent trimethylation of histone H3 at lysine 27 (H3K27me3) and SUV39H1/2-dependent H3K9me3 are important for lineage integrity of Th1 and Th2 cells (Tumes et al., 2013; Allan et al., 2012) , while G9a-mediated H3K9me2 has been shown to control inducible regulatory T (iTreg) and Th17 cell differentiation (Lehnertz et al., 2010; Antignano et al., 2014) . Importantly, KMTs are viable drug targets in a wide range of diseases (Schapira and Arrowsmith, 2016) . T hus, a better understanding of the epigenetic mechanisms controlling Th cell differentiation and lineage stability could offer new strategies to modulate dysregulated Th cell function in disease.
Recently, in a screen using chemical probes targeting KMTs, H3K79 methyltransferase Disruptor of telomeric silencing 1-like (DOT1L) was shown to be an important regulator of Th1 cell differentiation in both murine and human Th cells (Scheer et al., 2019) . DOT1L is the sole KMT for H3K79, performing mono-, di-and trimethylation in vivo (Min et al., 2003; Frederiks et al., 2008) since its knockout leads to a complete loss of H3K79 methylation (Jones et al., 2008) .
DOT1L-dependent H3K79 methylation has been suggested to directly promote transcriptional activation (Guenther et al., 2007; Steger et al., 2008) . However, H3K79me2 has also been correlated to silenced expression (Zhang et al., 2006) and was further associated with both gene activation and repression in the same cell for separate genes (Chen et al., 2018) . These reports highlight the lack of clarity of H3K79 methylation in mammalian gene transcription, and the role of H3K79 methylation in Th cells has not been described in detail.
Here, we identify a key role for DOT1L in limiting the Th1 cell differentiation program in both Th1 and Th2 cells. The absence of DOT1L in Th cells leads to an impaired Th2 cell response in vivo during infection with the helminth parasite Trichuris muris or during allergic airway inflammation, identifying DOT1L as a potential therapeutic target to treat diseases associated with dysregulated Th2 cell responses at mucosal sites.
RESULTS AND DISCUSSION
To begin to understand the precise role of DOT1L and H3K79 methylation in Th cell differentiation, we generated a T cell-specific DOT1L-deficient mouse strain (DOT1L ΔT mice) by crossing Dot1l fl/fl mice with Cd4 -Cre transgenic mice ( Fig. S1 ) and observed a specific reduction in DOT1L-dependent H3K79me2 levels within DOT1L-deficient T cells ( Fig. 1 A) . Consistent with our previous studies using the specific DOT1L inhibitor SGC0946 (Scheer et al., 2019) , we found that loss of DOT1L resulted in heightened expression of IFN-γ under Th1 cell-polarising conditions. We also observed an increase in IL-13 production by Th2 cells, suggesting that DOT1L is critical for restraining lineage-specific gene expression. However, most striking was the production of IFN-γ by a significant proportion of cells stimulated under Th2 cell-inducing conditions ( Fig. 1 B-D) . The increased frequency of IFN-γ-producing cells was associated with reduced frequencies of GATA3-positive cells and a concomitant increase in TBET-positive cells ( Fig. 1 E) . Thus, DOT1L appears to be critically required for silencing of lineage-promiscuous expression of TBET and IFN-γ in Th cells. This increased IFN-γ production occurred rapidly after activation ( Fig. 1 F) , but was not due to increased proliferation ( Fig. 1 G) . Titration of αCD3 antibody demonstrated that loss of DOT1L rendered T cells hyper-sensitive to activating signals, with increased IFN-γ observed at all concentrations of αCD3 ( Fig. 1 H) . In addition, stimulation of freshly purified Th cells with phorbol ester and calcium ionophore (PMA/Iono) in the absence of direct T cell receptor stimulation further demonstrated that DOT1L is required to limit Th cell activation and IFN-γ production independently of the T cell receptor ( Fig. 1 I) . Importantly, when we sorted naive (CD44 -CD62L + ) Th cells from control or DOT1L-deficient mice, we found that DOT1L was still required to limit IFN-γ production ( Fig. 1 J) . Taken together, these results identify DOT1L as a cell-intrinsic regulator of Th cell lineage choice that is critical for limiting Th1 cell differentiation.
As we observed lineage-promiscuous expression of IFN-γ in the absence of DOT1L, we next tested whether DOT1L was required for lineage stability of Th cells (Tumes et al., 2013; Allan et al., 2012) . We stimulated control or DOT1L-deficient Th cells under Th1-or Th2 cell-inducing conditions for three days, then washed and restimulated under opposing conditions for a further two days ( Fig. 2 A) . We found that the absence of DOT1L resulted in a loss of lineage integrity of both Th1 and Th2 cells. However, most striking was the loss of Th2 cell stability and the acquisition of IFN-γ production by a significant proportion of ex-Th2 cells, suggesting DOT1L is critical for silencing of Th1 cell lineage-specific genes in Th2 cells (Fig. 2 B) . To directly test if DOT1L was required to limit the Th1 cell differentiation program in bona fide Th2 cells or was more important in uncommitted activated Th cells in these cultures, we made use of IL-4/IL-13/IFN-γ triple reporter mice (IL-4-AmCyan; IL-13-dsRed; IFN-γ-YFP; CRY mice) mice to distinguish between committed Th1 (YFP + ) or Th2 (AmCyan + or dsRed + ) cells, or uncommitted but activated cells (Fig. 2 C) . We activated Th cells from DOT1L-sufficient and -deficient CRY mice for three days under Th1-or Th2 cell-inducing conditions, sorted IFN-γ/YFP + (Th1) or IL-4/AmCyan + or IL-13/dsRed + (Th2) cells and restimulated under the opposing condition for two days. Committed Th1 and Th2 cells generated from DOT1L-sufficient mice were stable, with <4% of cells switching following reactivation. Interestingly, loss of DOT1L had no effect on the switching of committed Th1 cells, suggesting that DOT1L was dispensable for Th1 cell lineage stability. However, strikingly a significant frequency (>30%) of DOT1L-deficient Th2 cells stimulated under Th1 cell polarising conditions produced IFN-γ ( Fig. 2 D) , showing that DOT1L is critically required to maintain Th2 cells through the inhibition of IFN-γ production.
We next tested whether the increased early expression of IFN-γ in the absence of DOT1L leads to heightened IFN-γ expression through a feed-forward loop in Th cells. Treatment of WT Th1 cells with neutralising antibodies against IFN-γ (αIFN-γ) resulted in a significant reduction in expression of IFN-γ ( Fig. 3 A, B) . In contrast, IFN-γ expression was not reduced by αIFN-γ treatment in the absence of DOT1L, highlighting that expression of IFN-γ in the absence of DOT1L is independent of an IFN-γ feed-forward mechanism ( Fig. 3 A, B ). In line with this, DOT1L-deficient Th2 cells express IFN-γ despite being generated in the presence of αIFN-γ and in the absence of IL-12 ( Fig. 3 C, D), identifying DOT1L as a critical cell-intrinsic regulator of the Th1 cell differentiation program. As αIFN-γ treatment failed to abolish IFN-γ production under both Th1-and Th2 cell-promoting conditions in the absence of DOT1L, we next analysed whether the transcription factor TBET was required for the expression of IFN-γ in these cells ( Fig. 3 A, C). To do this, we made use of T cell-specific TBET and DOT1L/TBET double knockout mice (TBET ΔT and DOT1L/TBET ΔT mice). While TBET-deficient WT Th cells fail to differentiate into IFN-γ-producing Th1 cells, the absence of DOT1L allows for moderate IFN-γ expression in the absence of TBET ( Fig. 3 A, B) . Although the addition of αIFN-γ to the Th1 cell-promoting conditions had no effect in the absence of DOT1L, the combined deletion of DOT1L and TBET resulted in a further reduction in the frequency of IFN-γ-producing cells, suggesting that the increased frequency of IFN-γ-producing cells in DOT1L-deficient mice is dependent on the expression of TBET. Consistent with this finding, the lineage-promiscuous expression of IFN-γ in Th2 cells was entirely dependent upon TBET, as DOT1L/TBET-deficient Th cells activated under Th2 cell-polarising conditions failed to produce any detectable levels of IFN-γ ( Fig. 3 C, D) . Thus, the dysregulated production of IFN-γ in Th1 and Th2 cells is TBET-dependent, suggesting that DOT1L deficiency affects the upstream Th1 cell lineage differentiation program rather than directly controlling IFN-γ expression.
Next, we made use of CRY mice to analyse the distribution of H3K79me2 in naive, or cultured and FACS-sorted bona fide Th1 or bona fide Th2 cells across the genome. Principal coordinate analysis (PCA) of three biological replicates showed high consistency within the samples of Th cell subsets and high diversity between groups ( Fig. 4 A) . H3K79me2 plot profiles of all genes ± 3 kb around the transcriptional start site (TSS) revealed increased coverage of H3K79me2 in all Th cell subsets around the TSS, consistent with a previous study (Wang et al., 2008) . Levels of H3K79me2 were increased in Th1 and Th2 cells compared to naive Th cells, suggesting increased H3K79me2 coverage at genes in activated Th cells ( Fig. 4 B) . In general, H3K79me2 levels were high in all Th cell subsets at lineage-specific and low at non-Th lineage specific genes, such as for Cd4 and Myod1 , respectively. Increased coverage at the genes for Ifng and Tbx21 in Th1, and Il13 and Gata3 in Th2 suggests that H3K79me2 is correlated with active, Th cell lineage-specific gene expression ( Fig. 4C ).
Our in vivo and ex vivo results using DOT1L ΔT mice suggest that DOT1L is a negative regulator of the Th1 cell differentiation program. However, our results show that methylation of H3K79 by DOT1L is primarily associated with transcriptional activity (Fig. 4 C) . We therefore performed genome-wide expression analysis by RNA-sequencing to understand the role of DOT1L-dependent H3K79me2 for specific gene expression in Th cells. PCA showed high similarities between the two biological replicates of each, naive Th, Th1 and Th2 samples from DOT1L ΔT mice or Cd4 -Cre + controls (Fig. 4 D) . Analysis of the number of up-and downregulated genes in Th cell subsets showed an increased number of genes with heightened levels in DOT1L-deficient Th cells ( Fig. 4 E) , identifying a potential inhibitory role for DOT1L in regulation of gene expression, despite the association of H3K79me2 with lineage-specific gene expression. MA-plots of significantly dysregulated genes (Th1/ Cd4 -Cre + or Th2/ Cd4 -Cre + ; FDR cut-off 0.05, absolute log fold >0.585 ≍ >1.5-fold) in the absence of DOT1L show similar Th1 cell differentiation program-associated upregulated genes in Th1 and Th2 polarised cells ( Fig. 4 F, G), which was partially already manifested in the unpolarised, naive state of the cells (Fig. 4 H) .
As our data suggests a correlation of H3K79me2 coverage with gene expression, we clustered genes from each Th cell subset by gene expression into low (<20 counts), mid (~500 counts) or high (top 450 expressed genes) and assessed the presence of H3K79me2 ± 3 kb around the TSS. Analysis of the clusters revealed that strength of gene expression correlated to coverage for H3K79me2 with highly expressed genes showing highest average H3K79me2 coverage ( Fig. 4 I) and little coverage for low expressed genes, which was independent of the Th cell subset ( Fig. S2 A (Th1) , Fig. 4 M (Th2) ). However, our analysis also revealed the heterogeneity within the group of highly expressed genes with regard to H3K79me2 coverage at the TSS.
Some highly expressed genes were highly enriched for H3K79me2 (subcluster "a"), while other highly expressed genes show little to no enrichment for H3K79me2 (subcluster "b") ( Fig. 4 J) .
This observation was less prominent in the clusters of intermediary expressed genes or in the cluster that showed low gene expression ( Fig. S2B ). We therefore analysed the genes in subclusters "a" and "b" for their expression in the absence of DOT1L. While genes in subcluster "a" showed a highly significantly reduced fold expression in the absence of DOT1L, genes in subcluster "b" showed a moderately reduced expression in the absence of DOT1L ( Fig. 4 K) , suggesting that DOT1L-dependent H3K79me2 is specifically required for maintaining the expression of a subset of highly expressed genes.
As we observed increased gene expression in the presence of H3K79me2 across the genome and a reduced Th1 cell differentiation program in the absence of DOT1L, we analysed whether the absence of DOT1L is associated with decreased expression of master regulators, such as TFs that inhibit the Th1 cell differentiation program. We found that 15 TFs were significantly downregulated across all Th cell subsets, seven of which are known to inhibit the Th1 cell differentiation program (red), five of which have not been defined with regard to their influence of the Th1 cell differentiation program (black) and three of which promote the Th1 cell differentiation program (green). Most prominently, the TFs BACH2, FOXP3 and NR4A3 were among the highest downregulated TFs across naive Th, Th1 and Th2 cells in the absence of DOT1L ( Fig. 4 L) , all of which have been correlated to limiting the Th1 cell differentiation program (Edwards et al., 2018; Yang et al., 2017; Sekiya et al., 2011) . As an example, BACH2 was one of the highest downregulated TF that inhibits the Th1 cell differentiation program and clustered within the highest H3K79me2 coverage across all Th cell subsets (Fig. 7M, Fig. S2 C) , suggesting a role of DOT1L and H3K79me2 in maintaining its gene expression across Th cell subsets and thereby limiting the Th1 cell differentiation program. Thus, DOT1L controls Th cell differentiation through direct and indirect mechanisms.
Our results demonstrate that DOT1L is critical for limiting Th1 cell responses and maintaining Th2 cell lineage integrity in vitro. To test whether DOT1L is required for protective Th2 cell responses in vivo, we infected control DOT1L FL/FL or DOT1L ΔT mice with the intestinal helminth parasite Trichuris muris . In this model, a high dose infection (~200 eggs) of WT mice results in the development of a protective Th2 cell-biased immune response, associated with goblet cell hyperplasia and mucus production, ultimately leading to worm expulsion. Following infection, DOT1L ΔT mice maintained a significant worm burden at day 21 post-infection ( Fig. 5 A, E) , developed a non-protective Th1 cell response, with high levels of IFN-γ and low levels of IL-13 ( Fig. 5 B, C) , or produced low levels of Trichuris -specific IgG1 (Fig. 5 D) . Further, treatment of mice with monoclonal antibodies against IFN-γ (αIFN-γ) failed to reduce the levels of IFN-γ and promote resistance to infection in the absence of DOT1L ( Fig. 5 A-E) . Thus, consistent with our in vitro results, DOT1L appears to be a T cell-intrinsic factor that is critical for limiting the development of Th1 cell responses.
Although protective in the context of helminth infection, Th2 cells are pathogenic in allergic inflammatory diseases such as asthma. To test if DOT1L deficiency prevented the development of pathogenic Th2 cells, we treated control DOT1L FL/FL or DOT1L ΔT mice intranasally with house dust mite antigen (HDM). HDM induces a cascade of type 2 immune responses, including group 2 innate lymphoid cells, Th2 cells, and culminating with the recruitment and activation of eosinophils into the lungs. Consistent with our findings in vitro and during helminth infection, loss of DOT1L in T cells during allergic lung inflammation resulted in a significant increase in IFN-γ expression and reduced levels of IL-13 ( Fig. 5 F) . This reduced type 2 response led to significantly fewer eosinophils (CD45 + SiglecF + CD11c neg ) in the lungs (Fig. 5 G) . These results suggest that targeting DOT1L could provide a new therapeutic strategy to limit pathogenic Th2 cell responses.
In summary, the experiments described here provide the first evidence of a pivotal role for DOT1L and H3K79me2 in Th1/Th2 cell differentiation and lineage integrity, which has a significant impact on immunity to infection and the development of inflammation. These findings place DOT1L as a central regulator of Th cell differentiation and identify this pathway as a potential therapeutic target to treat diseases associated with dysregulated Th cell responses. 
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METHODS
Mice
To create DOT1L FL/FL mice, we derived mice from DOT1L targeted ES cells ( Dot1ltm1a(KOMP)Wtsi, KOMP ID:29070) and crossed them with FLP mice (Monash University). Subsequently, DOT1L FL/FL mice were crossed with CD4-Cre (C57BL/6 background) to generate DOT1L ΔT mice ( Supplementary Fig. 1 ). DOT1L ΔT mice were crossed with IFN-γ-YFP reporter mice (Reinhardt et al., 2009) to create DOT1L ΔT IFN-γYFP mice. DOT1L ΔT CRY mice were generated by crossing DOT1L ΔT IFN-γYFP with 4C13R (Huang et al., 2015) mice.
DOT1L/TBET ΔT mice were created by crossing DOT1L ΔT and TBET ΔT (Intlekofer et al., 2008) .
Animals were maintained in a specific pathogen-free environment and used at 6-10 weeks of age and experiments were approved by the animal ethics committee of Monash University.
HDM model of allergic asthma
For the first 3 days of airway sensitization, mice were anesthetized under aerosolized isoflurane and intranasally instilled daily with 100 µg of house dust mite (HDM) antigen (Greer, Lenoir, NC) in 40 µl PBS. On days 13 to 17 post sensitization, mice were intranasally challenged daily with 25 µg of HDM antigen in 40 µl PBS before analysis on day 18. Bronchoalveolar lavage (BAL) was performed from the right lobes of the lung with three flushes of 800 µl PBS after clamping off the left lobe of the lung (used for histology and RNA isolation). BAL fluid and tissues were processed as previously described (Chenery et al., 2015) . In short, cells from BAL were incubated with 200 µl FcBlock (1:500 rat serum, 20 µg/ml αCD16/32, clone 93) and stained with antibodies against SiglecF, CD11c, CD45 for the identification of eosinophils (SSC high , SiglecF + , CD11c -, CD45 + ). 123count eBeads were added prior to analysis for enumeration of cells.
Trichuris muris infection
Propagation of Trichuris muris eggs and infections were performed as previously described (Antignano et al., 2011) . Mice were infected with 200 embryonated T. muris eggs by oral gavage to induce an intestinal infection over a period of 21 days. A subset of mice received 500 µg αIFN-γ (clone XMG1.2, BioXCell) in 200 µl PBS intraperitoneally at day 0, 4, 8, 12 and 16.
Sacrificed mice were assessed for worm burdens by manually counting worms in the ceca using a dissecting microscope.
T cell assays
CD4 + T cells were isolated from spleen and peripheral lymph nodes from indicated mice by negative selection using the EasySep™ Mouse CD4 + T Cell Isolation Kit (StemCell Technologies Inc). 1.75 x 10 5 cells were cultured for 4 days in RPMI1640 supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 25 mM HEPES, and 5 × 10 -5 M 2-mercaptoethanol with 1 μg/ml each of plate-bound αCD3 (clone 145-2C11) and αCD28 (clone 37.51). Cells were cultured under Th0 (IL-2, 10 ng/ml), Th1 (IL-2 and IL-12, 10 ng/ml each; αIL-4 10 µg/ml).
Western blot
T cells (CD4 + or CD8 + ) and B cells (CD19 + ) were sorted from the spleens of DOT1L ΔT or CD4-Cre mice and pellets were frozen at -80˚C. Histones were extracted from frozen cell pellets by incubating in 0.2 N HCl overnight at 4˚C. Supernatants were run on 12% SDS-PAGE gels.
H3K79me2 was detected using clone ab3594 (Abcam). A pan H3 antibody (ab1791, Abcam) was used as a loading control.
ELISA
T. muris -specific IgG1 was analysed as previously described. In short, ELISA plates were coated with o/n supernatant of adult worms, blocked with 10% NCS and serum was added in serial dilutions (1/20-1/2560). Secondary antibody (IgG1-HRP) was added at 1/1000 and incubated with 50 µl of TMB substrate until adequately developed. TMB substrate reaction was stopped by adding 50 µl of 1 N HCl and the plate was read at 450 nm.
Quantitative PCR
RNA from untreated lungs (clamped off during BAL) was isolated using 1 ml Trizol and mechanical disruption (one metal bead in a 2-ml-tube for 5 min and 60 Hz using the Qiagen TissueLyser LT) and chloroform extraction. CDNA was prepared using the High capacity cDNA reverse transcription kit (Applied Biosystems) according to the manufacturer's instructions.
QPCR was performed using SYBR green and the following primers: Ifng forward 5′-GGATGCATTCATGAGTATTGCC-3′, reverse 5′-CCTTTTCCGCTTCCTGAGG-3′; Il13 forward 5′-CCTGGCTCTTGCTTGCCTT-3′, reverse 5′-GGTCTTGTGTGATGTTGCTCA-3′; Actin b forward 5′-GGCTGTATTCCCCTCCATCG-3′, reverse 5′-CCAGTTGGTAACAATGCCATGT-3′.
RNA-sequencing
RNA was isolated from viable bona fide Th1 (YFP + ) or viable Th2 polarised cells of control (CD4Cre + ) and DOT1L ΔT mice after 4 days of culturing under Th1 and Th2 polarising conditions, respectively, using the NucleoSpin RNA Kit from Macherey&Nagel according to the manufacturer's instructions and sequenced on a MiSeq paired-end run (75 x 75, v3; Illumina).
Samples were aligned to the mm10 transcript reference using TopHat2, and differential expression was assessed using Cufflinks (Illumina). Visualization of the data was performed using DEGUST (https://github.com/drpowell/degust) and represent the average expression from 2 biological replicates. The RNA-Seq datasets described in this article are available at the National Center for Biotechnology Information (accession number GSE123966).
ChIP-qPCR and ChIP-sequencing preparation 1.5 x 10 6 sorted naive T cells (CD4 + CD44 -CD62L + ), bona fide Th1 (YFP + ) and bona fide Th2
(IL-4/IL-13 + ) cells from control (CRY mice) or DOT1L ΔT -CRY mice were fixed for 8 min with 0.6% formaldehyde in 10 ml complete RPMI1640 media on an overhead rotator at room temperature.
Fixing was stopped by adding 1 ml of 1.25 M glycine and incubating for 5 min on an overhead rotator at room temperature. Cells were pelleted at 600 x g for 5 min at 4˚C and washed twice with 10 ml ice cold PBS. Pellets were resuspended in 250 µl ChIP lysis buffer and stored at -80˚C. Cells were sonicated in 3 sets of 10 x 30 s ON, 30 s OFF at 4˚C using a Bioruptor 
